NCSA Chief Scientist Katz Named Inaugural Research Software Alliance Steering Committee Chair hpcwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hpcwire.com Daily Mail and Mail on Sunday newspapers.
Governor s Cup International Youth Match Racing Championship announces revised 2021 entries sail-world.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sail-world.com Daily Mail and Mail on Sunday newspapers.
Viracta Therapeutics to Host Key Opinion Leader Webinar
Virtual KOL event to focus on the unmet medical need in relapsed/refractory EBV-positive lymphoma and the design of NAVAL-1, a global pivotal trial
Event to take place on Thursday, May 20th at 2:00 PM ET
News provided by
Share this article
Share this article
SAN DIEGO, May 18, 2021 /PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX) (Viracta), a precision oncology company targeting virus-associated malignancies, will host a key opinion leader (KOL) webinar on nanatinostat and valganciclovir for the treatment of relapsed/refractory Epstein-Barr virus (EBV)-positive lymphoma on Thursday, May 20, 2021 at 2:00 PM ET.
The call will feature a presentation by KOLs
6월 중순부터 최저임금 본격 심의…사업장 4곳 현장방문 news1.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news1.kr Daily Mail and Mail on Sunday newspapers.